Topic prioritisation

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Decision date

Decision date

Prioritisation routing

Prioritisation routing

Decision

Decision

Showing 81 to 90 of 376

TitlePrioritisation routingDecisionDecision date
Ustekinumab for treating moderately to severely active ulcerative colitis in children aged 2 to 17 years [TSID 12128]None selectedNot selected
Berotralstat for preventing recurrent attacks of hereditary angioedema in children aged 2 to 12 years [TSID 12132]None selectedNot selected
Lebrikizumab for treating atopic dermatitis in children [TSID12133]None selectedNot selected
Ripretinib for treating advanced gastrointestinal stromal tumours after 3 or more treatments (review of TA881) [ID6496]None selectedAwaiting decision
Trastuzumab deruxtecan for treating HER2-positive unresectable or metastatic breast cancer after 1 or more anti-HER2 therapies (MA review TA704 and TA862) [ID5121]None selectedAwaiting decision
Avatrombopag for treating primary chronic immune thrombocytopenia in people 1 to 17 years [TSID12109]None selectedNot selected
NVK-002 for treating myopia in people 3 to 17 years [TSID11961]None selectedNot selected
Pitolisant for treating narcolepsy in children and young people 6 to 17 years ID6353None selectedNot selected
Transbronchial lung cryobiopsyNone selectedAwaiting decision
Noninvasive Vagus Nerve Stimulation For reactive airway diseaseNone selectedFurther information required

Results per page

  1. 10
  2. 25
  3. 50
  4. All